NBY NovaBay Operating Sales Margin

Brandmark of NovaBay Pharmaceuticals Inc. (NBY)

The projected operating margin helps assess the expansion of NovaBay Pharmaceuticals (NBY) into e-commerce and retail chains with Avenova drops. The value -249.10 reflects the metric's balance amid business maturity and the introduction of cosmetic lines. Growth relies on a staff of ophthalmologists attracted by social benefits and scientific research. This chart visualizes the efficiency of the company's core operations before tax deductions.

NBY - NovaBay Operating Profit Rate over the range 07/04/2022 - 04/18/2026

NovaBay Pharmaceuticals Inc. - analytical breakdowns and key metrics (NBY)

- share price and consensus valuation forecast:
Basic company analysis:NBY, NovaBay Pharmaceuticals Inc.
Finished products of NovaBay Pharmaceuticals, Inc.

Investors assess the asset's margin of safety through the share of core operating profit in total sales, which allows for the determination of cost management efficiency. A stable staff of biochemists and the targeted expansion of the sales network directly impact the operating profit-to-revenue ratio, turning this chart into an indicator of the fundamental stability of the NovaBay Pharmaceuticals (NBY) pharmaceutical business.